Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
MEDIROM Healthcare Technologies's Enterprise Value for the quarter that ended in Jun. 2025 was $39.83 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MEDIROM Healthcare Technologies's EBIT for the trailing twelve months (TTM) ended in Jun. 2025 was $-0.30 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEDIROM Healthcare Technologies EV-to-EBIT Related Terms
MEDIROM Healthcare Technologies EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Personal Services subindustry, MEDIROM Healthcare Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MEDIROM Healthcare Technologies EV-to-EBIT vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, MEDIROM Healthcare Technologies's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where MEDIROM Healthcare Technologies's EV-to-EBIT falls into.
MEDIROM Healthcare Technologies's current Enterprise Value is $36.43 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MEDIROM Healthcare Technologies's EBIT for the trailing twelve months (TTM) ended in Jun. 2025 was $-0.30 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEDIROM Healthcare Technologies (MRM) has a EV-to-EBIT of -121.45 as of Aug. 02, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on MEDIROM Healthcare Technologies and its competitors. According to the industry distribution chart, MEDIROM Healthcare Technologies ranks #999999 out of 70 companies in the Personal Services industry.
Is MEDIROM Healthcare Technologies' EV-to-EBIT too high?
MEDIROM Healthcare Technologies' current EV-to-EBIT is -121.45. Based on the distribution chart, MEDIROM Healthcare Technologies ranks #999999 out of 70 companies in the Personal Services industry, which is in the bottom quartile relative to peers. Overall, MEDIROM Healthcare Technologies has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MEDIROM Healthcare Technologies' EV-to-EBIT compare to EJH and DROR?
According to the Personal Services industry distribution chart, MEDIROM Healthcare Technologies ranks #999999 out of 70 companies for EV-to-EBIT. This places MEDIROM Healthcare Technologies in the lower half of its industry. The industry median EV-to-EBIT is 12.89. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Personal Services company?
The median EV-to-EBIT among Personal Services companies is 12.89, based on 70 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on MEDIROM Healthcare Technologies and its competitors. For the Personal Services industry, the median EV-to-EBIT is 12.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MEDIROM Healthcare Technologies's current EV-to-EBIT is -121.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDIROM Healthcare Technologies stock overvalued right now?
Based on GuruFocus' analysis, MEDIROM Healthcare Technologies (MRM) is currently considered Possible Value Trap. The stock's GF Value™ is $4.07, compared to a current price of $0.99 — trading 75.7% below its estimated fair value. The current EV-to-EBIT is -121.45. MEDIROM Healthcare Technologies' overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For MEDIROM Healthcare Technologies (MRM), the current EV-to-EBIT is -121.45 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MEDIROM Healthcare Technologies (MRM) Overvalued in 2026?
Based on GuruFocus' analysis, MEDIROM Healthcare Technologies stock appears to be undervalued.
The current stock price of $0.99 is trading 75.7% below its estimated GF Value™ of $4.07.
GuruFocus considers MEDIROM Healthcare Technologies to be Possible Value Trap.
Key valuation signals for MRM:
EV-to-EBIT: -121.45
GF Value™: $4.07 vs. price of $0.99 (75.7% below fair value)
No single metric tells the full story. See the MRM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
53GF Score
Get the complete analysis for MRM
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MRM has been successfully added to your 
